• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Hong Kong Web3 Festival Unveils 2026 Full Schedule: 4 Days of Insight-Driven Forums with Vitalik, Yi He, Justin Sun, Lily Liu, and More

    4/13/26 12:41:13 PM ET
    $HSDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care
    Get the next $HSDT alert in real time by email

    HONG KONG, April 13, 2026 (GLOBE NEWSWIRE) -- The Hong Kong Web3 Festival today released its full schedule for the 2026 edition, taking place from April 20 to 23 at the Hong Kong Convention and Exhibition Centre.

    Hong Kong Web3

    The four-day event will feature over 20 sessions across four stages, bringing together 200+ speakers, 100+ partners, and thousands of Web3 professionals, investors, and enthusiasts across the globe to explore trending topics in crypto finance, AI + Web3, and RWAs.

    Star-Studded Speaker Lineup

    The conference will convene top experts and leading Web3 projects. Confirmed speakers include:

    Paul CHAN Mo-po, GBM, GBS, MH, JP, Financial Secretary of the Government of  Hong Kong 

    Lu Weiding, Deputy to the People's National Congress, Vice Chairman to All-China Federation of Industry and Commerce, Chairman and CEO of Wanxiang Group

    Mr Joseph H. L. CHAN, JP, Under Secretary for Financial Services and the Treasury, Financial Services and the Treasury Bureau, Hong Kong

    Dr. YIP Chee Hang, Executive Director of Intermediaries, Securities and Futures Commission, Hong Kong

    Xiao Feng, Chairman of Wanxiang Blockchain, Chairman and CEO of HashKey Group

    Duncan Chiu, Legislative Council Member (Technology & Innovation Constituency), Hong Kong

    Vitalik Buterin, Co-Founder, Ethereum

    Michael Faulkender, Professor of Finance, University of Maryland; Former Deputy Secretary, the U.S. Treasury

    Yi He, Co-CEO, Binance

    Richard Teng, Co-CEO, Binance

    Lennix Lai, Chief Commercial Officer, OKX Global

    H.E. Justin Sun, Founder, TRON; Advisor, HTX; Advisor, B.AI

    Adeniyi Abiodun, Co-Founder & Chief Product Officer, Mysten Labs

    Lily Liu, President, Solana Foundation

    Joseph Chalom, CEO, Sharplink

    Francis B. Zhou, CEO, Quantum Solutions

    Abdelhamid Bizid, Managing Director, BlackRock

    Akhil Devmurari, Fintech Sector Head, APAC, Payments, J.P. Morgan

    Brian Mehler, CEO, Stable

    Franklin Bi, General Partner, Pantera Capital

    John Cahill, COO, Galaxy Digital Asia

    ......

    And 200+ industry leaders from traditional finance, tech giants, and Web3 projects.

    Daily Agenda Highlights

    Day 1 – April 20 

    The Web3 Festival opens with a Mainstage Opening Ceremony featuring distinguished representatives from the HKSAR government and top university leaders.

    In the afternoon, the Mainstage turns to TradFi x Crypto Finance: Convergence, where Yi He (Binance), Richard Teng (Binance), Lennix Lai (OKX), Bugra Celik (HSBC), Joseph Chalom (Sharplink), and Brian Mehler (Stable) among others, will discuss stablecoins, cross-border payments, and asset digitization.

    Stage 1 dives into Web3 x AI: Value Reconstruction in the Intelligence Age, featuring Sophia Jin (Byteplus), Ying YAN (Ant Digital Technologies), Keywolf (SlowMist), John (TON Foundation), Miguel Palencia (Qtum), Changhao Jiang (Cobo), and Jeffery Zeng (MaxQuant), among others.

    Stage 2 explores Tokenisation: Bridging the Real World with the Digital Economy (co-organized with Anvita), featuring Richa (MSX), Junny Ho (Kaspa), Cobe Zhang (Anvita & ZAN), and Chris Yin (Plume), among others.

    The Open Stage hosts Institutional Convergence: From Compliance to Commerce (partnered with Boundless).

    Day 2 – April 21

    The Mainstage morning session focuses on AI x Crypto: The Next Financial Infrastructure, with Lily Liu (Solana Foundation), Adeniyi Abiodun (Mysten Labs), and Justin Sun (TRON), among others.

    The afternoon Mainstage tackles Get to the Bottom of RWA, featuring Min Lin (Ondo Finance), Abdelhamid Bizid (BlackRock), and Cindy Xu (J.P. Morgan), among others.

    Stage 1 kicks off the morning with New Trends of Crypto-Equity Synergy, co-organized by Solana Company (NASDAQ:HSDT). In the afternoon, Stage 1 presents Smart Hardware: The Physical Interface and Extended Applications of Web3, co-organized with Arkreen.

    Stage 2 dedicates the full day to Stablecoins and Web3 Payment Revolution (co-organized with RD Technologies). 

    The Open Stage features project showcases from TCG.ZONE, K-Prop, HappyPlanet, and a HashKey Capital event.

    Day 3 – April 22 

    The Mainstage is powered by Ethereum Applications Guild for a full-day Ethereum Applications Gathering, featuring Vitalik Buterin and other Ethereum builders. 

    Stage 1 presents the Web3.0 Standardization and Globalization Summit. 

    Stage 2 hosts the HashKey Exchange Asia Connect Forum. 

    The Open Stage features Desun Singularity Tech and 0G. 

    Day 4 - April 23

    The Mainstage presents Bitfire Day: Institutional Digital Wealth Management Summit 2026. 

    Stage 1 features TON Day: AI Builders on Telegram Ecosystem. 

    Stage 2 hosts the Web3 Scholars Conference 2026. 

    The Open Stage closes with the *HashKey On-Chain Finance Summit 2026.

    Hong Kong Web3

    A Global Ecosystem of Partners 

    Hong Kong Web3 Festival 2026 has revealed an impressive lineup of 2026 sponsors, including:

    Title: OKX Wallet, SignalPlus, TRON

    Diamond: Bitfire, MEET48, ZA Bank

    Platinum: BAXS, Ethereum Applications Guild (EAG), Finanx AI, MSX, Qtum, TokenPocket, Web3 Leader Program, Zircon Securities

    Co-organizer: Anvita, Arkreen, RD Technologies, SNZ, Solana Company (NASDAQ:HSDT)

    Exclusive Dinner Sponsor: Sui Foundation

    Side-event Sponsor: Bitfire, DRK Lab, TON Foundation, W3SA-HK

    Gold: Alchemy Pay, AltLayer, BytePlus, ENI, MaxQuant, VeZoom

    Speaker & VIP Lounge Sponsor: Kaspa Ecosystem Foundation (KEF)

    Primary: bitbaby, CoinP, HappyMeta, Hong Kong Business School | Executive Education, Hotcoin, SlowMist, Websea, WEEK Labs

    Secondary: Aspire, CF_Blockchain, CHAINISLE, ChainUp, CoinPost, Conflux, Digital Reserve, Ellipal, Fufuture, Passey, PancakeSwap, PlatON, Questflow, SoonTech, United Stables, W3SA-HK, XKONG, Zbit

    Tertiary: ADVANCE.AI, Alpha Hunter, Ark of Panda, Black Water, BOT Chain, ChainSafeAI, Cloudflare, Cobo Global, DeSaFa, Doghead Foundation, EcoSync, Evolving Capital, Happy Planet, iCloser, MarsCat, MyDex, Orca Prime, Pauway Generator, QINGTENG, RWA.LTD, SimpleChain, StoneLink, Tencent Cloud, TiDB, Upay, XBIT, YUZHOU Technology

    Open Stage: 0G, Boundless, Delta & Capital, Desun Singularity Tech, Happy Planet, K-Prop, TCG.ZONE

    Exclusive Robot Partner: HK ROBOTICS

    Registration Still Open

    Tickets for the Web3 Festival 2026 are still available. For the full agenda, speaker updates, and registration, please visit: https://www.web3festival.org/hongkong2026/#/en

    Media Contact:



    Liu Linran

    [email protected]

    Disclaimer: This sponsored content is provided by the content provider and does not necessarily reflect the views of this media platform or its publisher. The information is shared for general informational purposes only and should not be considered financial, investment, or trading advice. Cryptocurrency and mining-related activities carry risks, including the potential loss of capital, and readers are encouraged to conduct their own research and seek professional advice where appropriate. Speculate only with funds that you can afford to lose.The media platform and publisher assume no responsibility for any losses or claims arising from reliance on this content. GlobeNewswire does not endorse any content on this page.

    Legal Disclaimer: This article is provided on an "as-is" basis, without warranties or representations of any kind, express or implied. The media platform assumes no responsibility or liability for the accuracy, content, completeness, legality, or reliability of the information presented. Any complaints, claims, or copyright concerns related to this article should be directed to the content provider mentioned above.

    Photos accompanying this announcement are available at



    https://www.globenewswire.com/NewsRoom/AttachmentNg/bbcc26a9-383e-4a1b-8094-506fb5791e98

    https://www.globenewswire.com/NewsRoom/AttachmentNg/451a82ae-dd9d-4694-b36c-8a738aac6e47



    Get the next $HSDT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $HSDT

    DatePrice TargetRatingAnalyst
    4/6/2026$4.00Buy
    Maxim Group
    11/15/2021Outperform → Market Perform
    Noble Capital Markets
    More analyst ratings

    $HSDT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Maxim Group resumed coverage on Solana Company with a new price target

    Maxim Group resumed coverage of Solana Company with a rating of Buy and set a new price target of $4.00

    4/6/26 8:28:30 AM ET
    $HSDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Helius Medical Tech downgraded by Noble Capital Markets

    Noble Capital Markets downgraded Helius Medical Tech from Outperform to Market Perform

    11/15/21 10:55:44 AM ET
    $HSDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Noble Capital Markets initiated coverage on Helius Medical with a new price target

    Noble Capital Markets initiated coverage of Helius Medical with a rating of Outperform and set a new price target of $20.00

    3/24/21 8:02:45 AM ET
    $HSDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $HSDT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Tjandrasuwita Agustina Gani

    3 - Solana Co (0001610853) (Issuer)

    4/6/26 9:27:13 PM ET
    $HSDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form 4 filed by Perkins Sherrie L

    4 - Solana Co (0001610853) (Issuer)

    4/2/26 5:00:33 PM ET
    $HSDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form 4 filed by Straw Edward M

    4 - Solana Co (0001610853) (Issuer)

    4/2/26 5:00:20 PM ET
    $HSDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $HSDT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Hong Kong Web3 Festival Unveils 2026 Full Schedule: 4 Days of Insight-Driven Forums with Vitalik, Yi He, Justin Sun, Lily Liu, and More

    HONG KONG, April 13, 2026 (GLOBE NEWSWIRE) -- The Hong Kong Web3 Festival today released its full schedule for the 2026 edition, taking place from April 20 to 23 at the Hong Kong Convention and Exhibition Centre. The four-day event will feature over 20 sessions across four stages, bringing together 200+ speakers, 100+ partners, and thousands of Web3 professionals, investors, and enthusiasts across the globe to explore trending topics in crypto finance, AI + Web3, and RWAs. Star-Studded Speaker Lineup The conference will convene top experts and leading Web3 projects. Confirmed speakers include: Paul CHAN Mo-po, GBM, GBS, MH, JP, Financial Secretary of the Government of  Hong Kong  Lu

    4/13/26 12:41:13 PM ET
    $HSDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Solana Company (NASDAQ: HSDT) Appoints Madelene Gani as Chief Operating Officer and Deputy CFO to Lead Next Phase of Growth

    Gani is a proven transformation leader with track record at Hedera Hashgraph, Aptos, Gemini Space Station, and JUUL Labs. She joins to accelerate Solana Company's next phase of growth.Gani brings deep financial and operational expertise in public companies, global financial infrastructure buildout, and operational scaling that has driven hundreds of millions in value creation across hyper-growth companies.Strategic hire signals Solana Company's commitment to institutional-grade operations as it expands its digital asset treasury and infrastructure globally. NEWTOWN, Pa., April 09, 2026 (GLOBE NEWSWIRE) -- Solana Company (NASDAQ:HSDT) today announced the appointment of Madelene Gani, CPA,

    4/9/26 4:15:00 PM ET
    $HSDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Solana Company Reports Fourth Quarter and Full Year 2025 Financial Results

    NEWTOWN, Pa., March 30, 2026 (GLOBE NEWSWIRE) -- Solana Company (NASDAQ:HSDT) (the "Company" or "HSDT"), a publicly listed company that has expanded its business to include a digital asset treasury ("DAT") dedicated to acquiring and holding Solana tokens ("SOL"), today announced results for the quarter and full year ended December 31, 2025. Fourth Quarter and Full Year Recent Business Updates Generated $5.1 million in staking rewards in the fourth quarter of 2025 and $5.5 million for the full year, as substantially all SOL holdings were staked throughout the periodRaised $29.9 million in 2025 through the Company's ATM programs, with proceeds used primarily to purchase SOL on an net asse

    3/30/26 4:05:00 PM ET
    $HSDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $HSDT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Andreeff Dane bought $8,229 worth of shares (1,284 units at $6.41) (SEC Form 4) (Amendment)

    4/A - HELIUS MEDICAL TECHNOLOGIES, INC. (0001610853) (Issuer)

    2/15/24 4:06:00 PM ET
    $HSDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Andreeff Dane bought $40,475 worth of shares (5,000 units at $8.10) (SEC Form 4)

    4 - HELIUS MEDICAL TECHNOLOGIES, INC. (0001610853) (Issuer)

    12/15/23 7:00:42 AM ET
    $HSDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Andreeff Dane bought $25,675 worth of shares (4,006 units at $6.41) (SEC Form 4)

    4 - HELIUS MEDICAL TECHNOLOGIES, INC. (0001610853) (Issuer)

    12/4/23 8:30:12 AM ET
    $HSDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $HSDT
    SEC Filings

    View All

    Solana Company filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - Solana Co (0001610853) (Filer)

    4/13/26 4:44:24 PM ET
    $HSDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form DEF 14A filed by Solana Company

    DEF 14A - Solana Co (0001610853) (Filer)

    4/10/26 4:05:17 PM ET
    $HSDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Solana Company filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Solana Co (0001610853) (Filer)

    4/9/26 5:18:07 PM ET
    $HSDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $HSDT
    Leadership Updates

    Live Leadership Updates

    View All

    Solana Company (NASDAQ: HSDT) Appoints Madelene Gani as Chief Operating Officer and Deputy CFO to Lead Next Phase of Growth

    Gani is a proven transformation leader with track record at Hedera Hashgraph, Aptos, Gemini Space Station, and JUUL Labs. She joins to accelerate Solana Company's next phase of growth.Gani brings deep financial and operational expertise in public companies, global financial infrastructure buildout, and operational scaling that has driven hundreds of millions in value creation across hyper-growth companies.Strategic hire signals Solana Company's commitment to institutional-grade operations as it expands its digital asset treasury and infrastructure globally. NEWTOWN, Pa., April 09, 2026 (GLOBE NEWSWIRE) -- Solana Company (NASDAQ:HSDT) today announced the appointment of Madelene Gani, CPA,

    4/9/26 4:15:00 PM ET
    $HSDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Solana Company Executive Chairman's Message: October 20th, 2025

    NEWTOWN, Pa., Oct. 20, 2025 (GLOBE NEWSWIRE) -- Today, Solana Company (NASDAQ:HSDT) released the following letter from the Executive Chairman: We are excited to enter the next phase of our lifecycle with a strong capital base and expanded accessibility for investors. This week will be remembered as a foundational moment for Solana Company (NASDAQ:HSDT). We have made the deliberate choice to move forward with our scheduled registration for resale of the shares purchased by investors in the recent private placement rather than delay it. Whereas some of our peers have decided to postpone it at the first sign of market volatility, we want to explain why we made this decision and why we feel

    10/20/25 10:18:15 AM ET
    $HSDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Helius Medical Technologies, Inc. Announces Authorized Claim for Payment by Major Healthcare Payer for its Portable Neuromodulation Stimulator (PoNS®) Device

    -Aetna authorizes claim for PoNS Device at out-of-network negotiated price of $18,350, becoming the third payer to join Anthem and United in providing PoNS reimbursement- -Out of Network reimbursement is only the first step towards expanding third-party paid access to PoNS- NEWTOWN, Pa., June 11, 2025 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ:HSDT) ("Helius" or the "Company"), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced an authorized claim for payment for the PoNS Device from a third major healthcare provider, Aetna Healthcare. "The recent reimbursement approvals from two major

    6/11/25 7:00:00 AM ET
    $HSDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $HSDT
    Financials

    Live finance-specific insights

    View All

    Solana Company Reports Fourth Quarter and Full Year 2025 Financial Results

    NEWTOWN, Pa., March 30, 2026 (GLOBE NEWSWIRE) -- Solana Company (NASDAQ:HSDT) (the "Company" or "HSDT"), a publicly listed company that has expanded its business to include a digital asset treasury ("DAT") dedicated to acquiring and holding Solana tokens ("SOL"), today announced results for the quarter and full year ended December 31, 2025. Fourth Quarter and Full Year Recent Business Updates Generated $5.1 million in staking rewards in the fourth quarter of 2025 and $5.5 million for the full year, as substantially all SOL holdings were staked throughout the periodRaised $29.9 million in 2025 through the Company's ATM programs, with proceeds used primarily to purchase SOL on an net asse

    3/30/26 4:05:00 PM ET
    $HSDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Solana Company to Release Fourth Quarter and Full Year 2025 Operating Results on March 30, 2026

    NEWTOWN, Pa., March 24, 2026 (GLOBE NEWSWIRE) -- Solana Company (NASDAQ:HSDT) (the "Company" or "HSDT"), a publicly listed company that has expanded its business to include a digital asset treasury dedicated to acquiring and holding Solana (SOL), today announced that the Company will release its fourth quarter and full year operating results on Monday, March 30, 2026, after market close. Management will host a conference call to discuss the results and provide an expanded business update as follows: Date:Monday, March 30, 2026Time:4:30 p.m. Eastern TimeWebcast:Click hereParticipant call link:Click here (register to receive unique PIN and dial-in number)   The webcast will be archived unde

    3/24/26 4:05:00 PM ET
    $HSDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Solana Company Reports Third Quarter 2025 Financial Results

    NEWTOWN, Pa., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Solana Company (NASDAQ:HSDT) (the "Company" or "HSDT"), a publicly listed company that has expanded its business to include a digital asset treasury ("DAT") dedicated to acquiring and holding Solana tokens ("SOL"), today announced results for the quarter ended September 30, 2025. Third Quarter and Recent Business Updates Closed partnership with Pantera Capital and Summer Capital of over $500 Million in funding in cash and stablecoins to launch SOL treasury strategyIssued cash-exercise warrants, allowing for a potential aggregate $750M additional capital raise for the CompanyLaunched ATM program, giving the company flexibility to raise addi

    11/18/25 4:05:00 PM ET
    $HSDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $HSDT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Helius Medical Technologies Inc.

    SC 13G/A - HELIUS MEDICAL TECHNOLOGIES, INC. (0001610853) (Subject)

    11/8/24 5:12:24 PM ET
    $HSDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form SC 13G filed by Helius Medical Technologies Inc.

    SC 13G - HELIUS MEDICAL TECHNOLOGIES, INC. (0001610853) (Subject)

    5/14/24 4:15:39 PM ET
    $HSDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form SC 13G/A filed by Helius Medical Technologies Inc. (Amendment)

    SC 13G/A - HELIUS MEDICAL TECHNOLOGIES, INC. (0001610853) (Subject)

    2/13/24 7:09:07 PM ET
    $HSDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care